Redeye strengthens its positive view of Formpipe following the Q4 report. While the EBIT figure, as previously disclosed, was weak, the ACV came in strong. Combined with announced cost cuts, it sets Formpipe for a substantial EBIT improvement in H2 2025.
LÄS MER